HEATHER BEAKLEY: Open Payments
NPI 1548753304 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,375 in 71 payments from 18 companies in 2025. Trend: 2023 $248 · 2024 $1,191 · 2025 $1,375
Food & beverage: $1,375
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $272 |
| Actelion Pharmaceuticals US, Inc. | 9 | $202 |
| Merck Sharp & Dohme LLC | 8 | $192 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| United Therapeutics Corporation | 3 | $82 |
| Alnylam Pharmaceuticals Inc. | 3 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $64 |
| BridgeBio Pharma, Inc. | 3 | $63 |
| Novo Nordisk Inc | 4 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
Products named: LEQVIO, WINREVAIR, OPSUMIT, Tyvaso, AMVUTTRA, UPTRAVI, WAINUA, JARDIANCE.
Industry payments across TN — which companies pay providers there.
